CN Patent

CN105126111A — 提高索拉非尼生物利用度的制剂

Assigned to Tsinghua University · Expires 2015-12-09 · 10y expired

What this patent protects

本发明提出了一种索拉非尼制剂，该索拉非尼制剂包含活性成份和高分子助溶剂，所述活性成份为选自索拉非尼、索拉非尼盐、索拉非尼衍生物或其前药的至少一种，所述高分子助溶剂具有乙酸乙烯酯基团。本发明的索拉非尼制剂具有药物活性成份生物利用度高的特点。

USPTO Abstract

本发明提出了一种索拉非尼制剂，该索拉非尼制剂包含活性成份和高分子助溶剂，所述活性成份为选自索拉非尼、索拉非尼盐、索拉非尼衍生物或其前药的至少一种，所述高分子助溶剂具有乙酸乙烯酯基团。本发明的索拉非尼制剂具有药物活性成份生物利用度高的特点。

Drugs covered by this patent

Patent Metadata

Patent number
CN105126111A
Jurisdiction
CN
Classification
—
Expires
2015-12-09
Drug substance claim
No
Drug product claim
No
Assignee
Tsinghua University
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.